IP Verse

Compositions For Use In Improving Stool Consistency Or Frequency In Infants Or Young Children - EP3264922

The patent EP3264922 was granted to Nestec on Oct 30, 2024. The application was originally filed on Mar 4, 2016 under application number EP16708971A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3264922

NESTEC
Application Number
EP16708971A
Filing Date
Mar 4, 2016
Status
Granted And Under Opposition
Sep 27, 2024
Publication Date
Oct 30, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CHR HANSENJul 29, 2025HOFFMANN EITLEADMISSIBLE
ABBOTTJul 23, 2025BOULT WADE TENNANTADMISSIBLE
FRIESLANDCAMPINA NEDERLANDJul 22, 2025FRIESLANDCAMPINA DEPARTMENTADMISSIBLE
NUTRICIAJul 21, 2025NEDERLANDSCH OCTROOIBUREAUADMISSIBLE

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5288637
DESCRIPTIONWO2004002495
DESCRIPTIONWO2005055944
DESCRIPTIONWO2012092156
DESCRIPTIONWO9610086
DESCRIPTIONWO9956754
EXAMINATIONUS2012172319
INTERNATIONAL-SEARCH-REPORTUS2009305996
INTERNATIONAL-SEARCH-REPORTUS2011207659
OPPOSITIONEP1972207
OPPOSITIONEP2454948
OPPOSITIONUS2006165670
OPPOSITIONUS2011207659
OPPOSITIONUS2012172319
OPPOSITIONUS2014371173
OPPOSITIONWO2008153391
OPPOSITIONWO2009077352
OPPOSITIONWO2012069415
OPPOSITIONWO2012156273
OPPOSITIONWO2012158517
OPPOSITIONWO2013032674
OPPOSITIONWO2013187764
OPPOSITIONWO2015071401
OPPOSITIONWO2016086151
OPPOSITIONWO2016139330

Non-Patent Literature (NPL) Citations (25) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- GIBSON GR; ROBERFROID MB., "Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics", J NUTR., (1995), vol. 125, pages 1401 - 1412, XP000972244
DESCRIPTION- OUWEHAND A.; BENNO Y. ET AL., "Probiotics: how should they be defined", TRENDS FOOD SCI. TECHNOL., (1999), vol. 10, pages 107 - 110, XP055150446
DESCRIPTION- WRODNIGG, T.M.; STUTZ, A.E., ANGEW. CHEM. INT. ED., (1999), vol. 38, pages 827 - 828
INTERNATIONAL-SEARCH-REPORT[XPYI] - BARBARA J. MARRIAGE ET AL, "Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants", JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, US, (20150706), vol. 61, no. 6, doi:10.1097/MPG.0000000000000889, ISSN 0277-2116, pages 649 - 658, XP055271350 [XP] 1,3-9,14,16 * page 653, column r, paragraph 3654 - page 654, column l, paragraph 1 * [Y] 10-13 [I] 1-17
OPPOSITION- Coccorullo, P. ; Strisciuglio, C. ; Martinelli, M. ; Miele, E. ; Greco, L. ; Staiano, A., "Lactobacillus reuteri (DSM 17938) in Infants with Functional Chronic Constipation: A Double-Blind, Randomized, Placebo-Controlled Study", JOURNAL OF PEDIATRICS., MOSBY-YEAR BOOK, ST. LOUIS, MO, US, US , (20101001), vol. 157, no. 4, ISSN 0022-3476, pages 598 - 602, XP027256213
OPPOSITION- D15 - Supplementary online material (Additional File 1) from https://doi.org/10.1186/s12937-022-00764-2 relating to D1
OPPOSITION- GIBSON G R, ROBERFROID M B, "DIETARY MODULATION OF THE HUMAN COLONIC MICROBIOTA: INTRODUCING THE CONCEPT OF PREBIOTICS", The Journal of Nutrition, American Society for Nutrition, US, US , (19950601), vol. 125, no. 06, ISSN 0022-3166, pages 1401 - 1412, XP000972244
OPPOSITION- PUBCHEM COMPOUND, (20050809), Database accession no. 3082169, XP093303469
OPPOSITION- "Stage 2 Follow-On Baby Formula", GNPD, MINTEL, Database accession no. 2617187, XP093303440
OPPOSITION- Vandenplas Yvan, Zakharova Irina, Dmitrieva Yulia, "Oligosaccharides in infant formula: more evidence to validate the role of prebiotics", British Journal of Nutrition, Cambridge University Press, UK, UK , (20150514), vol. 113, no. 9, doi:10.1017/S0007114515000823, ISSN 0007-1145, pages 1339 - 1344, XP093303457
OPPOSITION- Dupont C; Rivero M; Grillon C; Belaroussi N; Kalindjian A; Marin V, "α-Lactalbumin-enriched and probiotic-supplemented infant formula in infants with colic: growth and gastrointestinal tolerance", European Journal of Clinical Nutrition, Nature Publishing Group, GB, GB , (20100602), vol. 64, no. 7, doi:10.1038/ejcn.2010.81, ISSN 0954-3007, pages 765 - 767, XP037763202
OPPOSITION- CUMMINGS J H, MACFARLANE G T, "GASTROINTESTINAL EFFECTS OF PREBIOTICS", British Journal of Nutrition, Cambridge University Press, UK, UK , (20020501), vol. 87, no. SUPPL. 02, doi:10.1079/BJNBJN/2002530, ISSN 0007-1145, pages S145 - S151, XP009010412
OPPOSITION- Barbara J. Marriage, "Infants Fed a Lower Calorie Formula With 20FL Show Growth and 20FL Uptake Like Breast-Fed Infants", JPNG, (201512), vol. 61, doi:10.1097/MPG.0000000000000889, page 6, XP055271350
OPPOSITION- Puccio Giuseppe, Alliet Philippe, Cajozzo Cinzia, Janssens Elke, Corsello Giovanni, Sprenger Norbert, Wernimont Susan, Egli Delphine, Gosoniu Laura, Steenhout Philippe, "Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity : A Randomized Multicenter Trial", Journal of Pediatric Gastroenterology and Nutrition, Lippincott Williams Wilkins, Inc., US, US , (20170401), vol. 64, no. 4, doi:10.1097/MPG.0000000000001520, ISSN 0277-2116, pages 624 - 631, XP093303447
OPPOSITION- LING-NAN Bu, "Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation ", Pediatrics International, (2007), vol. 49, doi:10.1111/j.1442-200X.2007.02397.x, XP093284683
OPPOSITION- Esther Castanys-Muñoz, Maria J Martin, Pedro Antonio Prieto, "2′-fucosyllactose: an abundant, genetically determined soluble glycan present in human milk", Nutrition reviews, (20131201), vol. 71, no. 12, doi:10.1111/nure.12079, ISSN 0029-6643, pages 773 - 789, XP055271416
OPPOSITION- Alliet Philippe, Vandenplas Yvan, Roggero Paola, Jespers Sabine N. J., Peeters Stefaan, Stalens Jean-Philippe, Kortman Guus A. M., Amico Mailis, Berger Bernard, Sprenger Norbert, Cercamondi Colin I., Corsello Giovanni, "Safety and efficacy of a probiotic-containing infant formula supplemented with 2’-fucosyllactose: a double-blind randomized controlled trial", NUTRITION JOURNAL, BIOMED CENTRAL, GB, GB , vol. 21, no. 1, doi:10.1186/s12937-022-00764-2, ISSN 1475-2891, XP093303446
OPPOSITION- Mah Ka Weng, Chin Vanessa I L, Wong Wen Seen, Lay Christophe, Tannock Gerald W, Shek Lynette P, Aw Marion M, Chua Kaw Yan, Wong Hwee Bee, Panchalingham Anushia, Lee Bee Wah, "Effect of a Milk Formula Containing Probiotics on the Fecal Microbiota of Asian Infants at Risk of Atopic Diseases", Pediatric Research, Lippincott Williams & Wilkins, New York, US, US , (20071201), vol. 62, no. 6, doi:10.1203/PDR.0b013e31815991d5, ISSN 0031-3998, pages 674 - 679, XP093303472
OPPOSITION- Schaper Christin, Krowas Dirk, Braun Peggy G, "Probiotic bacteria in fermented dairy products Probiotische Kulturen in fermentierten Milchprodukten", ARCHIV FUER LEBENSMITTELHYGIENE - ARCHIVES OF MEAT, FISH ANDDAIRY SCIENCE, ALFELD, DE, DE , (20140101), vol. 65, no. 4, doi:10.2376/0003-925X-65-104, ISSN 0003-925X, pages 104 - 109, XP093303463
OPPOSITION- European Food Safety Authority, "Safety of 2′- O -fucosyllactose as a novel food ingredient pursuant to Regulation (EC) No 258/97", EFSA Journal, (20150701), vol. 13, no. 7, doi:10.2903/j.efsa.2015.4184, pages 4184 - 4184-32, XP055364481
OPPOSITION- Chmielewska Anna, Szajewska Hania, "Systematic review of randomised controlled trials:Probiotics for functional constipation", World Journal of Gastroenterology, WJG Press, CN, CN , (20100101), vol. 16, no. 1, doi:10.3748/wjg.v16.i1.69, ISSN 1007-9327, pages 69 - 75, XP093303439
OPPOSITION- Petra Amj Scholtens, "Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: A review", World Journal of Gastroenterology, WJG Press, CN, CN , (20140101), vol. 20, no. 37, doi:10.3748/wjg.v20.i37.13446, ISSN 1007-9327, page 13446, XP055286309
OPPOSITION- Papagaroufalis Konstantinos, Fotiou Aikaterini, Egli Delphine, Tran Liên-Anh, Steenhout Philippe, "A Randomized Double Blind Controlled Safety Trial Evaluating D-Lactic Acid Production in Healthy Infants Fed a Lactobacillus reuteri -containing Formula", Nutrition and Metabolic Insights, Libertas Academica Ltd., NZ, NZ , (20140101), vol. 7, doi:10.4137/NMI.S14113, ISSN 1178-6388, XP093303449
OPPOSITION- Kim Seong-Eun, Choi Suck Chei, Park Kyung Sik, Park Moo In, Shin Jeong Eun, Lee Tae Hee, Jung Kee Wook, Koo Hoon Sup, Myung Seung-Jae, "Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation", JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY JAN 2014, Korean Society of Neurogastroenterology and Motility, KW, KW , (20150101), vol. 21, no. 1, doi:10.5056/jnm14048, ISSN 2093-0879, pages 111 - 120, XP093303460
OPPOSITION- Bae Sun Hwan, "Diets for Constipation", Pediatric Gastroenterology, Hepatology & Nutrition, (20141201), vol. 17, no. 4, doi:10.5223/pghn.2014.17.4.203, ISSN 2234-8646, page 203, XP093303459

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents